Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | XBP1 | P17861 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.35 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12744265 | 1.00 | SIGMAR1 (0.43) | SIGMAR1CYP2A6ALDH1A1CYP1A2CRHR1 | |
| SCHEMBL14111969 | 1.00 | SIGMAR1 (0.43) | SIGMAR1CYP2A6ALDH1A1CYP1A2CRHR1 | |
| SCHEMBL29438473 | 1.00 | SIGMAR1 (0.43) | SIGMAR1CYP2A6ALDH1A1CYP1A2CRHR1 | |
| SCHEMBL18069061 | 1.00 | SIGMAR1 (0.43) | SIGMAR1CYP2A6ALDH1A1CYP1A2CRHR1 | |
| SCHEMBL12744264 | 1.00 | SIGMAR1 (0.43) | SIGMAR1CYP2A6ALDH1A1CYP1A2CRHR1 | |
| SCHEMBL15024679 | 0.98 | SIGMAR1 (0.42) | SIGMAR1CYP2A6ALDH1A1CYP1A2CRHR1 | |
| SCHEMBL19763126 | 0.98 | SIGMAR1 (0.42) | SIGMAR1CYP2A6ALDH1A1CYP1A2CRHR1 | |
| SCHEMBL25113130 | 0.97 | SIGMAR1 (0.41) | SIGMAR1CYP2A6ALDH1A1CYP1A2RAB9A | |
| SCHEMBL2607224 | 0.97 | SIGMAR1 (0.44) | SIGMAR1CYP2A6ALDH1A1CYP1A2CRHR1 | |
| SCHEMBL16386586 | 0.97 | SIGMAR1 (0.44) | SIGMAR1CYP2A6ALDH1A1CYP1A2CRHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2739701-B2 | A NOVEL COMPOSITION FOR RADIATION IMAGING DETECTOR AND A RADIATION IMAGING DETECTOR COMPRISING THE SAME | VIEWORKS CO LTD (KR) | 2019-07-24 | — | — | EP | claimed |
| EP-2739210-B2 | RADIATION IMAGING SYSTEM | VIEWORKS CO LTD (KR) | 2019-07-03 | — | — | EP | claimed |
| US-9459356-B2 | Composition for radiation imaging detector and a radiation imaging detector comprising the same | VIEWORKS CO., LTD. (KR) | 2016-10-04 | — | — | US | claimed |
| EP-2739210-B1 | RADIATION IMAGING SYSTEM | VIEWORKS CO LTD (KR) | 2016-02-10 | — | — | EP | claimed |
| EP-2739701-B1 | A NOVEL COMPOSITION FOR RADIATION IMAGING DETECTOR AND A RADIATION IMAGING DETECTOR COMPRISING THE SAME | VIEWORKS CO LTD (KR) | 2016-02-10 | — | — | EP | claimed |
| US-8759781-B2 | Radiation imaging system | VIEWORKS CO., LTD. (KR) | 2014-06-24 | — | — | US | claimed |
| EP-2739701-A2 | A NOVEL COMPOSITION FOR RADIATION IMAGING DETECTOR AND A RADIATION IMAGING DETECTOR COMPRISING THE SAME | Vieworks Co. Ltd. (KR) | 2014-06-11 | — | — | EP | claimed |
| EP-2739210-A2 | RADIATION IMAGING SYSTEM | Vieworks Co. Ltd. (KR) | 2014-06-11 | — | — | EP | claimed |
| US-20130032723-A1 | RADIATION IMAGING SYSTEM | VIEWORKS CO., LTD. (KR) | 2013-02-07 | — | — | US | claimed |
| WO-2013019076-A2 | A NOVEL COMPOSITION FOR RADIATION IMAGING DETECTOR AND A RADIATION IMAGING DETECTOR COMPRISING THE SAME | VIEWORKS CO.,LTD. (KR) | 2013-02-07 | — | — | WO | claimed |
| WO-2013019077-A2 | RADIATION IMAGING SYSTEM | VIEWORKS CO., LTD. (KR) | 2013-02-07 | — | — | WO | claimed |
| US-20060154159-A1 | Electrophotographic photoreceptor and electrophotographic imaging apparatus | SAMSUNG ELECTRONICS CO., LTD. | 2006-07-13 | — | — | US | claimed |
| US-5989737-A | Organic electroluminescent devices | XEROX CORPORATION (US) | 1999-11-23 | — | — | US | claimed |
| US-10439147-B2 | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | POWER OLEDS LIMITED (GB) | 2019-10-08 | — | — | US | disclosed |
| EP-2739701-B2 | A NOVEL COMPOSITION FOR RADIATION IMAGING DETECTOR AND A RADIATION IMAGING DETECTOR COMPRISING THE SAME | VIEWORKS CO LTD (KR) | 2019-07-24 | — | — | EP | disclosed |
| EP-2739210-B2 | RADIATION IMAGING SYSTEM | VIEWORKS CO LTD (KR) | 2019-07-03 | — | — | EP | disclosed |
| US-20060154159-A1 | Electrophotographic photoreceptor and electrophotographic imaging apparatus | SAMSUNG ELECTRONICS CO., LTD. | 2006-07-13 | — | — | US | disclosed |
| US-20060008672-A1 | Hole-trapping materials for improved OLED efficiency | EASTMAN KODAK COMPANY | 2006-01-12 | — | — | US | disclosed |
| US-5989737-A | Organic electroluminescent devices | XEROX CORPORATION (US) | 1999-11-23 | — | — | US | disclosed |
| US-5891587-A | ORGANIC ELECTROLUMINESCENT DEVICE COMPRISED OF ANODE, CATHODE, STARBURST AROMATIC AMINE COMPOUND | XEROX CORPORATION (US) | 1999-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10439147-B2 | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | NAT1, SLCO2A1, SLCO2B1 | SIGMAR1 402/4885CYP2A6 1385/4885ALDH1A1 789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.